Skip to main content
. 2017 Sep 8;24(5):790–796. doi: 10.1177/1076029617726599

Table 3.

Reclassification Table Among Patients With and Without VTE After First Cancer Treatment in Patients With Gastric Cancer.

Pretreatment KRS Posttreatment KRS
Frequency n (%) Intermediate High Total
Patients with VTE
 Intermediate 4 (100.0) 0 (0.0) 4
 High 4 (44.4) 5 (55.6) 9
8 5 13
Patients without VTE
 Intermediate 49 (100.0) 0 (0.0) 49
 High 29 (58.0) 21 (42.0) 50
78 21 99
112

Abbreviations: VTE, venous thromboembolism; KRS, Khorana score; N, number of patients.